Alan G. Fraser

10.7k total citations
132 papers, 3.8k citations indexed

About

Alan G. Fraser is a scholar working on Cardiology and Cardiovascular Medicine, Radiology, Nuclear Medicine and Imaging and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Alan G. Fraser has authored 132 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 82 papers in Cardiology and Cardiovascular Medicine, 30 papers in Radiology, Nuclear Medicine and Imaging and 23 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Alan G. Fraser's work include Cardiovascular Function and Risk Factors (38 papers), Cardiac Imaging and Diagnostics (24 papers) and Cardiac Valve Diseases and Treatments (21 papers). Alan G. Fraser is often cited by papers focused on Cardiovascular Function and Risk Factors (38 papers), Cardiac Imaging and Diagnostics (24 papers) and Cardiac Valve Diseases and Treatments (21 papers). Alan G. Fraser collaborates with scholars based in United Kingdom, Italy and Belgium. Alan G. Fraser's co-authors include Dragoş Vinereanu, Ann C. Tweddel, Michael Stephens, Nicholas Sculthorpe, Nicolae Florescu, Tamás Erdei, Michael Frenneaux, Paolo Marino, Mircea Cintezǎ and Sergio Sanchez‐Martinez and has published in prestigious journals such as The Lancet, Circulation and SHILAP Revista de lepidopterología.

In The Last Decade

Alan G. Fraser

126 papers receiving 3.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alan G. Fraser United Kingdom 32 2.8k 1.0k 631 612 369 132 3.8k
Francisco J. Chorro Spain 36 3.9k 1.4× 1.5k 1.4× 1.0k 1.6× 516 0.8× 382 1.0× 312 5.1k
Lilin She United States 23 2.7k 1.0× 751 0.7× 1.0k 1.6× 644 1.1× 349 0.9× 38 3.6k
M.D. Cheitlin United States 27 3.1k 1.1× 999 1.0× 1.1k 1.7× 826 1.3× 428 1.2× 250 4.0k
Charlotte Manisty United Kingdom 35 3.4k 1.2× 1.6k 1.5× 982 1.6× 563 0.9× 309 0.8× 177 4.7k
Frederick G. Kushner United States 7 1.8k 0.6× 1.1k 1.0× 805 1.3× 508 0.8× 337 0.9× 15 3.1k
Gillian Whalley New Zealand 36 4.1k 1.5× 821 0.8× 661 1.0× 480 0.8× 416 1.1× 155 5.1k
Leonardo De Luca Italy 33 2.9k 1.0× 643 0.6× 1.6k 2.6× 666 1.1× 438 1.2× 241 4.3k
Damien Logeart France 38 4.0k 1.4× 478 0.5× 821 1.3× 998 1.6× 447 1.2× 147 5.4k
André Lamy Canada 32 3.0k 1.1× 670 0.6× 1.6k 2.5× 368 0.6× 377 1.0× 130 4.2k
Matteo Di Biase Italy 34 2.8k 1.0× 938 0.9× 878 1.4× 460 0.8× 466 1.3× 255 3.9k

Countries citing papers authored by Alan G. Fraser

Since Specialization
Citations

This map shows the geographic impact of Alan G. Fraser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan G. Fraser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan G. Fraser more than expected).

Fields of papers citing papers by Alan G. Fraser

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alan G. Fraser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan G. Fraser. The network helps show where Alan G. Fraser may publish in the future.

Co-authorship network of co-authors of Alan G. Fraser

This figure shows the co-authorship network connecting the top 25 collaborators of Alan G. Fraser. A scholar is included among the top collaborators of Alan G. Fraser based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alan G. Fraser. Alan G. Fraser is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rademakers, Frank, Nico Bruining, Enrico G. Caiani, et al.. (2025). CORE-MD clinical risk score for regulatory evaluation of artificial intelligence-based medical device software. npj Digital Medicine. 8(1). 90–90. 4 indexed citations
2.
Melvin, Tom, Marc Dooms, Berthold Koletzko, et al.. (2024). Orphan and paediatric medical devices in Europe: recommendations to support their availability for on-label and off-label clinical indications. Expert Review of Medical Devices. 21(10). 893–901. 3 indexed citations
3.
Lübbeke, Anne, Christophe Combescure, Christophe Baréa, et al.. (2023). Clinical investigations to evaluate high-risk orthopaedic devices: a systematic review of the peer-reviewed medical literature. EFORT Open Reviews. 8(11). 781–791. 5 indexed citations
4.
Siontis, George C.M., Bernadette Coles, Jonas Häner, et al.. (2023). Quality and transparency of evidence for implantable cardiovascular medical devices assessed by the CORE-MD consortium. European Heart Journal. 45(3). 161–177. 14 indexed citations
5.
Fraser, Alan G., Bart Bijnens, Nico Bruining, et al.. (2023). Artificial intelligence in medical device software and high-risk medical devices – a review of definitions, expert recommendations and regulatory initiatives. Expert Review of Medical Devices. 20(6). 467–491. 27 indexed citations
6.
Lübbeke, Anne, Sergio Buccheri, Jan W. Schoones, et al.. (2023). Quality and Utility of European Cardiovascular and Orthopaedic Registries for the Regulatory Evaluation of Medical Device Safety and Performance Across the Implant Lifecycle: A Systematic Review. International Journal of Health Policy and Management. 12. 7648–7648. 9 indexed citations
7.
Moons, Philip, Tone M. Norekvål, Elena Arbelo, et al.. (2023). Placing patient-reported outcomes at the centre of cardiovascular clinical practice: implications for quality of care and management. European Heart Journal. 44(36). 3405–3422. 27 indexed citations
8.
Fraser, Alan G., et al.. (2022). A concise history of echocardiography: timeline, pioneers, and landmark publications. European Heart Journal - Cardiovascular Imaging. 23(9). 1130–1143. 28 indexed citations
9.
Marino, Paolo, et al.. (2021). Left Atrial Conduit Flow Rate at Baseline and During Exercise: An Index of Impaired Relaxation in HFpEF Patients. ESC Heart Failure. 8(5). 4334–4342. 9 indexed citations
10.
Cobbaert, Christa M., Ettore Capoluongo, Florent Vanstapel, et al.. (2021). Implementation of the new EU IVD regulation – urgent initiatives are needed to avert impending crisis. Clinical Chemistry and Laboratory Medicine (CCLM). 60(1). 33–43. 17 indexed citations
11.
Fraser, Alan G., Piotr Szymański, Elizabeth Macintyre, & Martin Landray. (2020). Regulating drugs, medical devices, and diagnostic tests in the European Union: early lessons from the COVID-19 pandemic?. European Heart Journal. 41(23). 2140–2144. 4 indexed citations
12.
Tabassian, Mahdi, Tamás Erdei, Sergio Sanchez‐Martinez, et al.. (2018). Diagnosis of Heart Failure With Preserved Ejection Fraction: Machine Learning of Spatiotemporal Variations in Left Ventricular Deformation. Journal of the American Society of Echocardiography. 31(12). 1272–1284.e9. 76 indexed citations
13.
Erdei, Tamás, Otto A. Smiseth, Paolo Marino, & Alan G. Fraser. (2014). A Systematic Review of Diastolic Stress Tests in Heart Failure with Preserved Ejection Fraction, with Proposals from the EU-FP7 MEDIA Study Group. European Journal of Heart Failure. 16(12). 1345–1361. 63 indexed citations
14.
Fraser, Alan G., et al.. (2013). Ultrasonic imaging of the carotid arteries, from intima-media thickness to histological markers for plaque vulnerability: what do we know?. 18(2). 87–98. 4 indexed citations
15.
Yousef, Zaheer, et al.. (2009). A Critical Comparison of Echocardiographic Measurements Used for Optimizing Cardiac Resynchronization Therapy: Stroke Distance is Best. European Journal of Heart Failure. 11(8). 779–788. 38 indexed citations
16.
Metra, Marco, Dirk L. Brutsaert, Kenneth Dickstein, et al.. (2007). Treatment of Advanced Chronic Heart Failure with Normal Left Ventricular Ejection Fraction. Response to the letter by Dr. Martinez-Selles. European Journal of Heart Failure. 9(12). 1224–1225. 1 indexed citations
17.
Fraser, Alan G.. (2003). Feasibility and Reproducibility of Off-line Tissue Doppler Measurement of Regional Myocardial Function During Dobutamine Stress Echocardiography. European Journal of Echocardiography. 4(1). 43–53. 80 indexed citations
18.
Fraser, Alan G., et al.. (1996). Prevention of infective endocarditis: enthusiasm tempered by realism.. PubMed. 54(7). 341–7. 4 indexed citations
19.
Spes, C, et al.. (1996). Doppler analysis of pulmonary venous flow profiles in orthotopic heart transplant recipients: a comparison with mitral flow profiles and atrial function.. ORCA Online Research @Cardiff (Cardiff University). 85(10). 753–60. 7 indexed citations
20.
Fraser, Alan G., Alan Rees, Stephanie B. Matthews, & Geraint T. Williams. (1988). The haggis tolerance test in Scots and Sassenachs.. BMJ. 297(6664). 1632–1634. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026